Visibility Score
63/100
AI Mentions
985
AI Search Volume
505.0K
As of June 25, 2026, Mindray (mindray.com) has an AI visibility score of 63 out of 100, based on 985 total AI mentions across platforms like Google AI Overview and ChatGPT. The brand generates 505.0K AI search volume. Compared to peers in the life sciences sector, Mindray ranks #2 of 6 in AI mention share of voice.
Mindray is a China-based medical device company in the Patient Monitoring segment, registered with the U.S. FDA. This report tracks how Mindray appears in AI search — ChatGPT, Google AI Overview and other answer engines.
AI Visibility Breakdown
Mindray has 985 total AI mentions across 2 tracked platforms, generating 505.0K in AI search volume. Google AI Overview accounts for the largest share at 96% of mentions.
By Platform
Brand Entities
No brand entity data available.
Where AI Sources Its Answers About Mindray
When AI assistants answer questions involving Mindray, these are the domains they most often cite. Winning AI visibility means being present and referenced on the sources the model actually reads — which is rarely a company's own website.
Share of Voice vs Competitors
Mindray ranks #2 out of 6 competitors in AI mention share of voice, capturing 10% of total mentions. Dexcom leads with 7.8K AI mentions. Competitors tracked include Dexcom, Masimo, Embecta, Tandem Diabetes Care.
AI Mentions
Comparison
| Company | Mentions | AI Vol |
|---|---|---|
| dexcom.com (Dexcom) | 7.8K | 14.7M |
| mindray.com (You) | 985 | 505.0K |
| masimo.com (Masimo) | 430 | 94.2K |
| embecta.com (Embecta) | 127 | 25.6K |
| tandemdiabetes.com (Tandem Diabetes Care) | 85 | 1.5K |
| nihonkohden.com (Nihon Kohden) | 60 | 6.9K |
Improve your brand's AI visibility
This is a static snapshot. VayoMed helps life sciences brands monitor AI mentions, track competitors, and build the content and citation signals that make AI platforms more likely to recommend them.